Literature DB >> 16200041

Repeat biopsy in patients with initial diagnosis of PIN.

Massimo De Matteis1, Cristina Poggi, Antonietta De Martino, Barbara Corti, Libero Barozzi, Pietro Pavlica.   

Abstract

PURPOSE: Prostatic intra-epithelial neoplasia (PIN) is considered a pre-malignant lesion and the main precursor of invasive prostatic adenocarcinoma. A PIN diagnosis established by prostate needle biopsy poses a difficult clinical management problem. We retrospectively reviewed our three-year experience in order to identify criteria for referring patients to repeat biopsy.
MATERIALS AND METHODS: We reviewed the repeat biopsy records of 72 patients in whom PIN had been detected on initial US-guided needle biopsy of the prostate. All the patients had a minimum of 6 biopsy cores taken, and they all had PSA > 4 ng/ml.
RESULTS: Adenocarcinoma was detected in 15 patients out of 50 (30%) with an initial diagnosis of low-grade PIN and in 10 patients out of 22 (45.4%) with high grade PIN, in 7 out of 18 (39%) in whom PSA levels had decreased during the observation interval, in 16 patients out of 46 (35%) in whom the PSA had increased and in 2 patients out of 8 (25%) with stable PSA.
CONCLUSIONS: Our results seem to confirm that PIN can be considered a precursor of prostatic adenocarcinoma or a histological alteration often associated with it. Patients with low-grade PIN and particularly those with high-grade PIN should be regularly subjected to repeat biopsy at short intervals due to the high frequency of the final diagnosis of carcinoma. No agreement has been reached on the time interval between the first and the second biopsy. The PSA changes during the observation period are not a statistically significant parameter to suggest the repetition of prostatic biopsy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16200041

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  2 in total

1.  Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer.

Authors:  Oleksandr N Kryvenko; Michelle Jankowski; Dhananjay A Chitale; Deliang Tang; Andrew Rundle; Sheri Trudeau; Benjamin A Rybicki
Journal:  Mod Pathol       Date:  2012-03-30       Impact factor: 7.842

2.  TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia.

Authors:  Kyung Park; James T Dalton; Ramesh Narayanan; Christopher E Barbieri; Michael L Hancock; David G Bostwick; Mitchell S Steiner; Mark A Rubin
Journal:  J Clin Oncol       Date:  2013-12-02       Impact factor: 44.544

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.